Follow us...


Search News Archives

News Channels


Coronavirus (COVID-19)


View Channel

New Laboratory Products


View Channel

Lab News


View Channel

Research & Case Studies


View Channel

Microscopy | Image Analysis


View Channel

Separation Science


View Channel



View Channel

Events | Webinars


View Channel

Conferences | Events

Fimmic Raises €5M Series a Round to Accelerate Scaling of its Deep Learning AI Cloud for Tissue Diagnostics

publication date: Dec 22, 2017
author/source: Fimmic

Fimmic, a Finnish medtech company developing Deep Learning AI solutions for digital medical microscopy, announced today that it has closed a €5M investment round to accelerate scaling of its WebMicroscope® AI Cloud for tissue diagnostics.

FimmicLed by new investor Ascend Capital Partners, the round brings the Company’s total raised funds in 2017 to €6.6M. Existing investors, including ACME Investments and STO-Rahoitus, also participated this round. 

Fimmic’s WebMicroscope is the first commercial platform that supports pathologists and medical researchers in tissue diagnostics through deep learning AI-based image analysis. 

WebMicroscope aims to improve the speed and accuracy of diagnosis which translates into more precise and personalized patient care. Fimmic’s WebMicroscope was recently nominated as the winner of the Innovation Award for Artificial Intelligence-based Digital Pathology Solution by Frost & Sullivan. 

“Our AI algorithms have been successfully used in various applications ranging from cancer research to drug development projects on Parkinson’s disease and liver diseases,” says Kaisa Helminen, CEO of Fimmic. “The results are extremely promising and our technology has received great interest from various industries and application areas. With this investment we are now able to grow the team, expand our marketing actions and launch our local activities in the US market,” she concludes.

“Artificial Intelligence (AI) holds great potential in several fields of medicine, including tissue diagnostics,” says Monita Mo, CEO of Ascend Capital Partners. “We were impressed about the expertise in the Fimmic team and their proven track record in executing development plans for a commercial product. We are excited to offer our experience and contact network to support Fimmic in their global expansion.” 

Fimmic, founded in 2013, is a spin-off company from the Finnish Institute for Molecular Medicine at the University of Helsinki. The next-generation WebMicroscope AI Platform was launched in spring 2017 and has since been used in a wide range of image analysis applications globally.

more about fimmic




Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd



Media Partners